Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Nuklearmedizin

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    February 2016
  1. RUHLMANN M, Binse I, Bockisch A, Rosenbaum-Krumme SJ, et al
    Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


    January 2016
  2. KNIE B, Plotkin M, Zschieschang P, Prasad V, et al
    A family with pheochromocytoma-paraganglioma inherited tumour syndrome. Serial 18F-DOPA PET/CT investigations.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


    December 2015
  3. WELZ F, Sanders JC, Kuwert T, Maler J, et al
    Absolute SPECT/CT quantification of cerebral uptake of 99mTc-HMPAO for patients with neurocognitive disorders.
    Nuklearmedizin. 2015;55.
    PubMed     Text format     Abstract available


  4. HOFFMEISTER K, Preuss R, Weise R, Burchert W, et al
    The effect of beta blocker withdrawal on myocardial SPECT modeled from adenosine 13N-ammonia PET.
    Nuklearmedizin. 2015;55.
    PubMed     Text format     Abstract available


  5. MULLER FH, Farahati J, Muller AG, Gillman E, et al
    Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
    Nuklearmedizin. 2015;55.
    PubMed     Text format     Abstract available


    November 2015
  6. ZHANG Y, Shi H, Li B, Cai L, et al
    The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
    Nuklearmedizin. 2015;54:255-61.
    PubMed     Text format     Abstract available


    October 2015
  7. YILMAZ S, Aliyev A, Ekmekcioglu O, Ozhan M, et al
    Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  8. BIERSACK HJ, Stelzner F, Knapp FF
    Discovery of rhenium and masurium (technetium) by Ida Noddack-Tacke and Walter Noddack. Forgotten heroes of nuclear medicine.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  9. KAPFHAMMER A, Winkens T, Lesser T, Reissig A, et al
    Enhancing 18F-FDG-PET/CT analysis in lung cancer patients. Is CT-CT image fusion helpful in predicting pleural involvement? A pilot study.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  10. JUN S, Kim H, Nam HY
    A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. A study in patients with papillary thyroid carcinoma.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    September 2015
  11. SCHAEFER WM, Meyer A, Knollmann D
    Lung ventilation/perfusion SPECT for diagnosing pulmonary embolism. Is the required minimal P/V count rate ratio fulfilled in routine situation? Results from a multicentre survey.
    Nuklearmedizin. 2015;54:217-22.
    PubMed     Text format     Abstract available


  12. KOBE C, Kuhnert G, Haverkamp H, Fuchs M, et al
    Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    August 2015
  13. WIMMER I, Minear G, Brustbauer R, Gotzinger P, et al
    Pancreatic VIPoma visualized by 68Ga DOTA-NOC PET-CT.
    Nuklearmedizin. 2015;54:N32-3.
    PubMed     Text format    


    July 2015
  14. RAGER O, Baskin A, Amzalag G, Buchegger F, et al
    Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  15. WEISS M, Schwarz F, Wallmichrath J, Baumeister R, et al
    Chylothorax and chylous ascites. Clinical utility of planar scintigraphy and tomographic imaging with SPECT/CT.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  16. PICCARDO A, Puntoni M, Morbelli S, Massollo M, et al
    18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  17. WUEST W, Lell M, May MS, Saake M, et al
    Thoracic non-osseous lesions in cancer patients detected in low-dose CT images acquired as part of skeletal SPECT/CT examinations.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    June 2015
  18. STEINHOFF KG, Hankir M, Krause K, Tonjes A, et al
    Interaction of thyroid hormone with brown adipose tissue. Lessons learned from PET-CT.
    Nuklearmedizin. 2015;54:82-7.
    PubMed     Text format     Abstract available


  19. FULARZ M, Adamiak P, Czepczynski R, Jarzabek-Bielecka G, et al
    Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    April 2015
  20. EZZIDDIN S, Khalaf F, Seidel M, Al Zreiqat A, et al
    Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy. A new tool to differentiate psoriatic from rheumatoid arthritis.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    February 2015
  21. LORENZ R, Buck A, Reiners C
    In-patient nuclear medicine therapy in Germany from 2010 to 2012. Analysis of structured quality reports.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  22. FIETHEN S, Schlieper G, Mottaghy FM, Heinzel A, et al
    [Detektion einer pleuro-peritonealen Leckage bei Peritonealdialyse mit Hilfe der Peritonealszintigraphie mit SPECT/CT].
    Nuklearmedizin. 2015;54:N4-5.
    PubMed     Text format    


  23. SCHREITER V, Steffen I, Huebner H, Bredow J, et al
    Ventilation/perfusion SPECT/CT in patients with pulmonary emphysema. Evaluation of software-based analysing.
    Nuklearmedizin. 2015;54:31-5.
    PubMed     Text format     Abstract available


  24. KOTZERKE J, Oehme L, Grosse J, Hellwig D, et al
    [Positron emission tomography 2013 in Germany. Results of the query and current status.]
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    November 2014
  25. BRAEUNING U, Pfannenberg C, Gallwitz B, Teichmann R, et al
    11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.
    Nuklearmedizin. 2014;54.
    PubMed     Text format     Abstract available


  26. KALTENBACH TE, Graeter T, Mason RA, Kratzer W, et al
    Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue(R)) with quantified 18F-FDG-PET-CT.
    Nuklearmedizin. 2014;54.
    PubMed     Text format     Abstract available


    October 2014
  27. TSAI SC, Ou YC, Cheng CL, Li JR, et al
    Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.
    Nuklearmedizin. 2014;54.
    PubMed     Text format     Abstract available


  28. SZTURZ P, Prasek M, Rehak Z, Fabian P, et al
    Unicentric Castleman disease: from screening mammography to PET/CT imaging.
    Nuklearmedizin. 2014;53:N41-3.
    PubMed     Text format    


    September 2014
  29. KUPITZ D, Apostolova I, Lange C, Ulrich G, et al
    Global scaling for semi-quantitative analysis in FP-CIT SPECT.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    August 2014
  30. RAUSCH I, Bergmann H, Geist B, Schaffarich M, et al
    Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


  31. DUNZINGER A, Decker J, Kieberger A, Weis S, et al
    Unusual loss of FDG uptake in recurrent GIST.
    Nuklearmedizin. 2014;53:N35-7.
    PubMed     Text format    


  32. KIM HA, Yoon SH, Yoon JK, Lee SJ, et al
    Salivary gland scintigraphy in Sjogren's syndrome. Comparison of the diagnostic performance of visual and semiquantitative analysis.
    Nuklearmedizin. 2014;53:139-45.
    PubMed     Text format     Abstract available


    January 2014

  33. Proceedings and abstracts of the 52nd Annual Congress of the German Nuclear Medicine Society, March 26-29, 2014, Hanover, Germany.
    Nuklearmedizin. 2014;53:N3.
    PubMed     Text format    


  34. KOTZERKE J
    [Structured review].
    Nuklearmedizin. 2014;53:N3.
    PubMed     Text format    


  35. GIOVANELLA L, Treglia G, Ceriani L, Verburg F, et al
    Detectable thyroglobulin with negative imaging in differentiated thyroid cancer patients. What to do with negative anatomical imaging and radioiodine scan?
    Nuklearmedizin. 2014;53:1-10.
    PubMed     Text format     Abstract available


  36. LINDNER O, Burchert W, Schafers M, Schaefer W, et al
    [Myocardial perfusion scintigraphy 2012 in Germany. Results of the 6th Query].
    Nuklearmedizin. 2014;53:13-8.
    PubMed     Text format     Abstract available


  37. PAK K, Kim SJ, Kim IJ, Kim DU, et al
    Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma.
    Nuklearmedizin. 2014;53:26-31.
    PubMed     Text format     Abstract available


  38. PIRICH C, Keinrath P, Rettenbacher L, Rendl G, et al
    99mTc tetrofosmin myocardial perfusion scintigraphy in CAD. Performance with early and standard delayed acquisition and fractional flow reserve.
    Nuklearmedizin. 2014;53:111-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: